Description
Trastuzumab deruxtecan, sold under the brand name Enhertu, It is licensed for the treatment of Non-small cell lung cancer (NSCLC), Stomach cancer, HER2 positive gastric / gastro-oesophageal cancer.
It is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the topoisomerase I inhibitor deruxtecan (a derivative of exatecan). It is licensed for the treatment of breast cancer or gastric or gastroesophageal adenocarcinoma.
It was approved for medical use in the United States in December 2019, in Japan in March 2020, in the European Union in January 2021, and in Australia in October 2021. Trastuzumab deruxtecan is the first approved therapy by the US Food and Drug Administration (FDA) targeted to people with the HER2-low breast cancer subtype subset of HER2-negative breast cancer.
NEWS / Updates
Written By
Mr. Sandeep Tomar (D. pharma)
Last updated
26 Sep 2024 | 05:03 AM (IST)
FAQs
Is ENHERTU launched in India?
Yes, Enhertu has been launched in India. It is available with Aark Pharmaceuticals.
What’s the cost price of ENHERTU?
Patients with a valid prescription, can send a request at Aark to get the best price of ENHERTU in India. It can be delivered anywhere in India within 24-48 hours.
How to get ENHERTU from Specialty Medicine Distributor in India?
ENHERTU is available in India, to get or place an order from Specialty Medicine Distributor in India, please call us at+91 9999156233, You can also make an inquiry by emailing us at sales@aarkpharma.co.in, sales@aarkpharma.com, WhatsApp: +91 9999156233.
Note: Prior to consuming any medications, including “trastuzumab deruxtecan”, it is advisable to seek guidance from a medical professional regarding its therapeutic advantages, usage instructions, and potential side effects.
Get Access In India
How to get access to FDA approved ENHERTU (trastuzumab deruxtecan) for injection in India?
Aark can help you to get access prescription medicines for personal use, FDA approved ENHERTU (trastuzumab deruxtecan) for injection in India. We have delivered Anti-cancer medicines -ENHERTU (trastuzumab deruxtecan) for injection to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
Disclaimer
Disclaimer: We hereby declare that Aark Pharmaceuticals exclusively exports biosimilars or generic medicines manufactured in India. We do not export products manufactured by multinational companies. Our commitment lies in offering cost-effective healthcare solutions through generic medications, ensuring accessibility and affordability for all our customers. For any inquiries or assistance regarding our product range, please feel free to contact us.
